Enlaza Therapeutics
San Diego, United States· Est.
Enlaza Therapeutics is developing a novel platform to create covalent biologic medicines, such as antibodies, for treating serious diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $161M
About
Enlaza Therapeutics is developing a novel platform to create covalent biologic medicines, such as antibodies, for treating serious diseases.
BiologicsAntibodiesOncology
Funding History
2Total raised:$161M
Series A$100M
Seed$61M